ALKS Alkermes Plc.
Pharmaceutical Preparations · Nasdaq · SEC EDGAR official
Market Value*
$4.66B
Revenue (FY)
$1.48B 2025-12-31
Net Income (FY)
$241.66M
P/E (float-based)
19.3
company.
Pharmaceutical Preparations · Nasdaq · SEC EDGAR official
company.